http://events.ubm.com/ About Generics and Biosimilars in Central and Eastern Europe:

The pharmaceutical market of Central & Eastern Europe is estimated to reach US$104.2 billion by 2016. Following this trend the CEE market of generics and biosimilars is expected to expand between 2013 and 2016, as many of big pharma''s blockbuster drugs reach the expiry of patent protection. Hosted by CPhI Conferences, this inaugural, two-day event will highlight opportunities in the region and facilitate in-depth discussion between leading CEE, European and Global generics and biosimilars manufacturers, pharmaceutical and biotech companies, regulators, leading industry experts and key decision makers. Focusing on opportunities and challenges in and outside the region, senior directors, partners and board members will discuss trends in generic and biosimilar development, manufacturing and commercialisation.
]]> Wed, 22 May 2013 00:08:07 GMT en